Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis and treatment of scalp itch require differentiating between various conditions using a proposed five-step evaluation process.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Scientists have made progress in creating replacement teeth, hair, and glands that work, which could lead to new treatments for missing teeth, baldness, and dryness conditions.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Lupus can look like hair loss from alopecia areata but needs different treatment.

People with Down's syndrome often have more skin problems due to a weak immune system.

Minoxidil may cause heart changes; use caution and monitor patients with heart conditions.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Immune cells affect hair growth and could lead to new hair loss treatments.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Somatostatin may help protect hair follicles from immune attacks.

Stump-tailed macaque best for researching hair loss causes and treatments.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Using neurohormones to control keratin can lead to new skin disease treatments.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Artificial skin is improving wound healing and shows potential for treating different types of wounds.

Cronkhite-Canada Syndrome often leads to death within 6-18 months.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.